Declaration PAN Europe regarding RIVM Statement of PAN Europe regarding the contents of her report ‘A Poisonous Injection’ June 26, 2014.
Average participation in the National Immunisation Programme in the Netherlands around 95% From the RIVM report 'Vaccination level of the National Immunisation Programme of the Netherlands' (report year 2014) the strong commitment of Community Health Services (GGD’s) and child welfare ce
Examine patients with acute Q fever again after a year If patients with acute Q fever are re-examined for antibodies one year after their infection, 98% of the patients with chronic Q fever can be detected.
Antibiotic resistance no longer increasing but vigilance remains necessary After continuing to rise for many years, in 2013 the prevalence of resistance to antibiotics levelled out somewhat in both hospitals and primary care.
Need for reliable data on ammonia emissions Many countries in Europe and Central Asia have a need for reliable data on ammonia emissions. These data include ammonia emissions inventories and monitoring of abatement measures.
RIVM forecasting study: a healthier Netherlands with more people living with a chronic disease Dutch people are reaching an increasingly advanced age: in 2030, the life expectancy of men will be 82 years, and of women, 85.
Animation Antibiotic Resistance RIVM monitors and informs the government about potential national health threats with regard to antibiotic resistance. Based on a national AMR surveillance system trends are monitored.
Twenty million post-polio patients are dealing with severe complaints on a daily basis The second European Polio Conference takes place in Amsterdam from 25 - 27 June 2014, with the theme of the ‘Post-Polio Syndrome, A Condition without Boundaries’.
International top conference about antibiotic resistance On 25 and 26 June, an international conference about resistance to antibiotics - an increasing worldwide problem - will take place in The Hague.
Paracetamol taken to prevent side effects lowers the response to vaccination RIVM has investigated the effect of paracetamol on the immune system of adolescents.